Clinical trial Recruiting at 1 site Interventional Ages 59 and up

Physical exercise program for older adults in a rural area

Official title: Impact of a Physical Exercise Program on the Physical, Podiatric and Mental Health of the Adult Population in a Rural Area

Run by University of Valencia · NCT06842849 · Data updated 2026-11-12

This project tests whether a community exercise program increases weekly moderate-to-vigorous physical activity measured by an accelerometer in adults over 59 compared with new participants and active controls.

Quick facts

Study typeInterventional
Ages59 Years and up
SexAll
Enrollment140 (estimated)
SponsorUniversity of Valencia
Academic / other
Locations1 site (Valencia)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedJuly 30, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 11, 2026
Trial IDNCT06842849 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 60 and older (over 59) in the Enguera area who can wear an accelerometer for seven days and participate safely in a group exercise program.

Probably not a fit

Patients who cannot meet accelerometer wear-time requirements, have acute illness during data collection, or have health limitations that prevent participation in exercise are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This quasi-experimental comparison enrolls three groups of community-dwelling adults over 59: long-term participants in the 'Enguera Sé Saludable' program, newly enrolled participants, and active controls who do not attend the program. Weekly moderate-to-vigorous physical activity (MVPA) is measured objectively with an ActiGraph accelerometer worn for seven days, using predefined daily wear-time thresholds. Participants must meet accelerometer wear criteria and provide informed consent, and those with insufficient wear time or acute illness during data collection are excluded. The work is led by the Universitat de València and is conducted in the municipality of Enguera.

Why it matters

Potential benefit: If successful, the program could increase weekly MVPA in older adults and support wider rollout of community-based exercise to improve function and quality of life.

How similar studies have gone: Previous community-based exercise programs for older adults have often increased activity levels and physical function, though accelerometer-confirmed comparisons in rural municipal programs are less common.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults over 59 years of age.
* Patients who comply with accelerometer times for 7 days.
* Patients who correctly complete the accelerometer registration sheet.
* Patients who complete the informed consent

Exclusion Criteria:

* Patients who do not wear the accelerometer 600 minutes a day for at least 3 days on weekdays and 480 minutes for at least 1 day on the weekend.
* Patients who suffer from illness during data collection.
* Patients who do not wear the accelerometer for 7 days. Be in IPAQ category 1 (low level of AF).

Where it's running

  • Universitat de València
    Valencia, Spain
    Recruiting

Study contacts

  • Principal investigator: Carmen García Gomariz — Universitat de Valéncia Departamento D'infermeria
  • Study coordinator: CARMEN GARCÍA GOMARIZ, Phd
  • Email: Carmen.garcia-gomariz@uv.es
  • Phone: 637787861

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.